Details of the Drug

General Information of Drug (ID: DM8CYOP)

• Drug Name: 1,3-Dihydro-naphtho[2,3-d]imidazol-2-one
• Synonyms: 1H-Naphtho[2,3-d]imidazol-2(3H)-one; 5649-76-3; CHEMBL316599; 1,3-Dihydro-naphtho[2,3-d]imidazol-2-one; SCHEMBL17206226; SCHEMBL11357960; ZINC13824637; BDBM50007236; FCH995480; AKOS024262366; 1H-Naphth[2,3-d]imidazol-2(3H)-one; AJ-64431; AX8292028; 1,3-Dihydro-2H-naphth[2,3-d]imidazol-2-one

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 184.19
  Logarithm of the Partition Coefficient (xlogp); 1.8
  Rotatable Bond Count (rotbonds); 0
  Hydrogen Bond Donor Count (hbonddonor); 2
  Hydrogen Bond Acceptor Count (hbondacc); 1
• Chemical Identifiers:
  Formula: C11H8N2O
  IUPAC Name: 1,3-dihydrobenzo[f]benzimidazol-2-one
  Canonical SMILES: C1=CC=C2C=C3C(=CC2=C1)NC(=O)N3
  InChI: InChI=1S/C11H8N2O/c14-11-12-9-5-7-3-1-2-4-8(7)6-10(9)13-11/h1-6H,(H2,12,13,14)
  InChIKey: HUOPXZLFTBYAML-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 13724742
  TTD ID: D0T3UP

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Phosphodiesterase 3A (PDE3A)	TT06AWU	PDE3A_HUMAN	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Phosphodiesterase 3A (PDE3A)	DTT	PDE3A	3.33E-01	1.35E-02	0.14

References

• [1] 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones--inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation. J Med Chem. 1991 Sep;34(9):2906-16.